Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: no known allergies / adverse drug reactions attending: chief complaint: hcc, gallbladder polyp major surgical or invasive procedure: segment 3 mass resection, cholecystectomy, intraoperative ultrasound. history of present illness: per dr. note as follows: 53-year-old asian male with chronic hbv infection who has been followed for hepatoma screening and a 5-mm gallbladder polyp. an ultrasound on , demonstrated a suspicious lesion in the right lobe of his liver. the liver biopsy on , was negative for malignancy. he had a mildly elevated afp to 13.4 on . an mri on , demonstrated an irregular arterial phase rim enhancing mass within segment 3 of the liver suggestive of a hepatoma. an eus on , demonstrated an irregular mass in the left lobe of the liver that was hypoechoic, heterogeneous and solid measuring 17 x 20 mm. a fine-needle aspiration was performed and it was interpreted as moderately-differentiated hepatocellular carcinoma. he is now brought to the operating room after informed consent was obtained for segment 3 mass resection and cholecystectomy. his preoperative afp had increased to 99.1. he had a normal hematocrit of 40.2, platelets 182,000, ast 29, alt 40, alkaline phosphatase 50 and total bilirubin 0.3, albumin 5.1. past medical history: diabetes mellitus, hbv, h/x of a 5-mm gallbladder polyp. no prior surgical history. . social history: married and has two children. he is currently unemployed. family history: mother-75 and healthy. father died at age 58 of unknown causes. physical exam: vitals: the patient was afebrile, nontachycardic, nontachypneic. gen:aaox3. nad card: rrr. pulm: sounds present b/l. abd: soft. appropriately tender in the epigastrum and ruq. incision c/d/i estremities: no edema. good capillary refill. pertinent results: 10:45am blood wbc-12.7*# rbc-4.66 hgb-14.4 hct-41.7 mcv-90 mch-30.9 mchc-34.4 rdw-12.3 plt ct-197 04:30am blood wbc-5.8 rbc-3.85* hgb-12.0* hct-34.3* mcv-89 mch-31.1 mchc-34.9 rdw-12.3 plt ct-199 06:05am blood pt-13.8* ptt-30.1 inr(pt)-1.2* 04:30am blood glucose-198* urean-11 creat-0.7 na-136 k-4.0 cl-95* hco3-28 angap-17 04:30am blood calcium-8.5 phos-3.1 mg-2.1 brief hospital course: on , he underwent a segment 3 mass resection, cholecystectomy, intraoperative ultrasound. the patient was admitted to the hepatobiliary surgical service. after a brief, uneventful stay in the pacu, the patient arrived on the floor npo, on iv fluids and antibiotics, with a foley catheter, and having receieved it morphine for pain control. the patient was hemodynamically stable. neuro: the patient received it morphine and subsequently a dilaudid pca with good effect and adequate pain control. when tolerating oral intake, the patient was transitioned to oral pain medications. cv: the patient remained stable from a cardiovascular standpoint; vital signs were routinely monitored. pulmonary: the patient remained stable from a pulmonary standpoint; vital signs were routinely monitored. good pulmonary toilet, early ambulation and incentive spirrometry were encouraged throughout hospitalization. gi/gu/fen: post-operatively, the patient was made npo with iv fluids. diet was advanced when appropriate, which was well tolerated. once it wwas ensured that the patietn was tolerating a diet, his home dose of metforming was also restarted. patient's intake and output were closely monitored, and iv fluid was adjusted when necessary. electrolytes were routinely followed, and repleted when necessary. id: the patient's white blood count and fever curves were closely watched for signs of infection. endocrine: the patient's blood sugar was monitored throughout his stay; insulin dosing was adjusted as necessary. home metformin was restarted once patientw as eating. hematology: the patient's complete blood count was examined routinely; no transfusions were required during his stay on the surgical floor. prophylaxis: the patient received subcutaneous heparin and venodyne boots were used during this stay; was encouraged to get up and ambulate as early as possible. at the time of discharge, the patient was doing well, afebrile with stable vital signs. the patient was tolerating a regular diet, ambulating, voiding without assistance, and pain was well controlled. the patient received discharge teaching and follow-up instructions with understanding verbalized and agreement with the discharge plan. medications on admission: metformin 850 mg p.o. twice daily and entecavir 1 mg p.o. daily discharge medications: 1. entecavir 1 mg tablet sig: one (1) tablet po daily (daily). 2. metformin 850 mg tablet sig: one (1) tablet po bid (2 times a day). 3. hydromorphone 2 mg tablet sig: 1-2 tablets po q4h (every 4 hours) as needed for pain. disp:*30 tablet(s)* refills:*0* discharge disposition: home discharge diagnosis: hcc segment iii liver resection and ccy dm discharge condition: mental status: clear and coherent. level of consciousness: alert and interactive. activity status: ambulatory - independent. discharge instructions: please call dr. office if you have any of the following: fevers, chills, nausea, vomiting, increased abdominal pain or distension, incision redness/bleeding/drainage or constipation/diarrhea you may shower no heavy lifting/straining no driving while taking pain medication followup instructions: , rn coordinator for dr. , will call you with a follow up appointment in 1 week md, procedure: cholecystectomy partial hepatectomy diagnoses: cirrhosis of liver without mention of alcohol diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled malignant neoplasm of liver, primary chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta primary central sleep apnea other acute postoperative pain cholesterolosis of gallbladder 

Answer: The patient is high likely exposed to